Metformin exerts antidepressant effects by regulated DNA hydroxymethylation

Epigenomics. 2019 May;11(6):655-667. doi: 10.2217/epi-2018-0187. Epub 2019 Feb 13.

Abstract

Aim: We aim to study the antidepressant mechanism of metformin. Materials & methods: Tail suspension test and forced swimming test were used to detect the depression-like behavior; the expressions of target protein were examined by western blot; the levels of target genes were tested by quantitative PCR; the content of α-ketoglutarate and 5hmC were detected by ELISA kit. Results: We showed that metformin can improve the depression-like behavior in spatial restraint stress model; then we found that metformin through AMPK/Tet2 pathway increasing the expression of BDNF to antidepression. Conclusion: Our study provided evidences that metformin plays a role of antidepressant effects through the AMPK/Tet2/BDNF pathway.

Keywords: AMPK; BDNF; Tet2; hydroxymethylation; metformin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology*
  • Brain-Derived Neurotrophic Factor / metabolism
  • Cells, Cultured
  • DNA Methylation*
  • Dexamethasone / pharmacology
  • Male
  • Metformin / pharmacology*
  • Mice, Inbred ICR
  • Prefrontal Cortex / metabolism

Substances

  • Antidepressive Agents
  • Bdnf protein, mouse
  • Brain-Derived Neurotrophic Factor
  • Dexamethasone
  • Metformin